Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 25 versus DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 25 versus DEXTROSE 4 IN MODIFIED LACTATED RINGER S IN PLASTIC CONTAINER.
DEXTROSE 25% vs DEXTROSE 4% IN MODIFIED LACTATED RINGER'S IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose (D-glucose) is a monosaccharide that provides caloric support. It is transported into cells via glucose transporters (GLUTs) and undergoes glycolysis to produce ATP. It increases blood glucose levels, providing substrate for cellular metabolism.
Dextrose provides glucose for cellular energy metabolism. Lactated Ringer's solution replaces extracellular fluid and electrolytes. Lactate is metabolized to bicarbonate in the liver, providing buffering capacity for metabolic acidosis.
Adults: 25 grams (100 mL of 25% solution) intravenously as a single dose for hypoglycemia. May repeat if needed based on blood glucose monitoring.
Intravenous infusion; adult dose is 500-1000 mL per 24 hours, titrated to fluid and electrolyte needs.
None Documented
None Documented
Terminal half-life is approximately 30-60 minutes due to rapid cellular uptake and metabolism. Clinical context: In hyperinsulinemic states or insulin therapy, half-life is shortened; in renal/hepatic impairment, half-life may be prolonged but glucose is quickly cleared.
2–4 hours (intravenous). Clinical context: reflects glucose clearance; prolonged in renal impairment.
Dextrose is completely metabolized to carbon dioxide and water. Excretion: Renal (0% unchanged), Biliary/Fecal (negligible). Essentially 100% metabolized.
Renal: >99% as glucose. Biliary/fecal: negligible (<1%).
Category C
Category C
IV Fluid
IV Fluid